Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

被引：62
|
作者：
Martinez-Baz, Ivan [1 ,2 ,3 ]
Miqueleiz, Ana [3 ,4 ]
Casado, Itziar [1 ,2 ,3 ]
Navascues, Ana [3 ,4 ]
Trobajo-Sanmartin, Camino [3 ,4 ]
Burgui, Cristina [1 ,2 ,3 ]
Guevara, Marcela [1 ,2 ,3 ]
Ezpeleta, Carmen [3 ,4 ]
Castilla, Jesus [1 ,2 ,3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[3] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain
[4] Complejo Hosp Navarra, Dept Clin Microbiol, Pamplona, Spain
来源：
EUROSURVEILLANCE | 2021年 / 26卷 / 21期
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.2807/1560-7917.ES.2021.26.21.2100438
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
COVID-19 vaccine effectiveness was evaluated in close contacts of cases diagnosed during January-April 2021. Among 20,961 contacts, 7,240 SARS-CoV-2 infections were confirmed, with 5,467 being symptomatic and 559 leading to hospitalisations. Non-brand-specific one and two dose vaccine effectiveness were respectively, 35% (95% confidence interval (CI): 25 to 44) and 66% (95% CI: 57 to 74) against infections, 42% (95% CI: 31 to 52) and 82% (95% CI: 74 to 88) against symptomatic infection, and 72% (95% CI: 47 to 85) and 95% (95% CI: 62 to 99) against COVID-19 hospitalisation. The second dose significantly increased effectiveness. Findings support continuing complete vaccination.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] COVID-19 vaccines and decreased transmission of SARS-CoV-2
    Vitiello, A.
    Ferrara, F.
    Troiano, V
    La Porta, R.
    INFLAMMOPHARMACOLOGY, 2021, 29 (05) : 1357 - 1360
  • [22] COVID-19 vaccines and decreased transmission of SARS-CoV-2
    A. Vitiello
    F. Ferrara
    V. Troiano
    R. La Porta
    Inflammopharmacology, 2021, 29 : 1357 - 1360
  • [23] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
  • [24] Epidemiology of SARS-CoV-2 infection and COVID-19
    Salzberger, B.
    Buder, F.
    Lampl, B.
    Ehrenstein, B.
    Hitzenbichler, F.
    Hanses, F.
    INTERNIST, 2020, 61 (08): : 782 - 788
  • [25] Infection with SARS-CoV-2 is not the same as covid-19
    Bamji, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [26] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2025, 51 (01) : 139 - 156
  • [27] Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
    Mazagatos, Clara
    Monge, Susana
    Olmedo, Carmen
    Vega, Lorena
    Gallego, Pilar
    Martin-Merino, Elisa
    Jose Sierra, Maria
    Limia, Aurora
    Larrauri, Amparo
    EUROSURVEILLANCE, 2021, 26 (24) : 1 - 6
  • [28] Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults
    Lior Rennert
    Zichen Ma
    Christopher S. McMahan
    Delphine Dean
    Nature Communications, 13
  • [29] Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults
    Rennert, Lior
    Ma, Zichen
    McMahan, Christopher S.
    Dean, Delphine
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [30] Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
    Castilla, Jesus
    Lecea, Oscar
    Martin Salas, Carmen
    Quilez, Delia
    Miqueleiz, Ana
    Trobajo-Sanmartin, Camino
    Navascues, Ana
    Martinez-Baz, Ivan
    Casado, Itziar
    Burgui, Cristina
    Egues, Nerea
    Ezpeleta, Guillermo
    Ezpeleta, Carmen
    EUROSURVEILLANCE, 2022, 27 (33)
12345